China's GSK probe motivated solely by wish to curb corruption

The major pharmaceutical multinational GlaxoSmithKline is being investigated by the Chinese authorities for anti-trust and bribery offences. More on the South China Morning Post. Read previous post. GlaxoSmithKline (GSK:LN), (GSK:London) is a Global Compact participant since 2007/08/10.